The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches-Reference-Cited by-同舟云学术

The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation—implications for preventative treatment approaches

Published:2014-07 Issue:7 Volume:16 Page:927-933
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Jain Natasha A.,Lu Kit,Ito Sawa,Muranski Pawel,Hourigan Christopher S.,Haggerty Janice,Chokshi Puja D.,Ramos Catalina,Cho Elena,Cook Lisa,Childs Richard,Battiwalla Minoo,Barrett A. John

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference51 articles.

1. Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes;Nichols;Blood,2001

2. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection;Nichols;J Infect Dis,2002

3. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy;Boeckh;Blood,2004

4. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study;Boeckh;Blood,1996

5. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007;Griffiths;Herpes,2008

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2024-08

2. IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation;Journal of Clinical Investigation;2024-04-01

3. Cytomegalovirus related hospitalization costs among hematopoietic stem cell and solid organ transplant recipients treated with maribavir versus investigator‐assigned therapy: A US‐based study;Transplant Infectious Disease;2024-01-14

4. Investigation of Clinical Features and Association between Vascular Endothelial Injury Markers and Cytomegalovirus Infection Associated with Thrombotic Microangiopathy in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Case-Based Research;International Journal of Molecular Sciences;2024-01-09

5. Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy;Cellular Immunology;2024-01